NCT05249114 2025-03-10Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine TumorsProvidence Health & ServicesPhase 1 Active not recruiting6 enrolled
NCT04949282 2022-12-23SEPTRALUSociedad Española de Medicina Nuclear e Imagen MolecularRecruiting5,000 enrolled